R

Rancho Santa Fe Bio, Inc.

4 employees

Rancho Santa Fe Bio develops cardiovascular drugs to slow the progression of calcification in patients with aortic valve stenosis.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Product Design
Therapeutics

Date founded

2019

Funding rounds raised

R

Rancho Santa Fe Bio, Inc. raised undisclosed on August 21, 2021

Investors: Oxford Angel Fund

FAQ